Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Objective We evaluated the respective value of insulin, C-peptide and proinsulin levels in 33 patients with endogenous hyperinsulinism and in 67 controls to determine the best parameters and thresholds to make or to rule out the diagnosis of endogenous hyperinsulinism. Results When blood glucose levels were below 2.5 mmol/l, insulin was 0.2 nmol/l in all insulinomas but not in the nesidioblastosis or in the controls; proinsulin was >5 pmol/l in all patients but not in the controls. When fasting blood glucose levels reached 2.5-3.3 mmol/l, proinsulin was 22 pmol/l in 74% of the patients. Proinsulin after an overnight fast was below 22 pmol/l in all non-obese controls and above 22 pmol/l in 73% of non-obese patients. Conclusion Proinsulin levels above 5 pmol/l with blood glucose levels below 2.5 mmol/l during a 72 h fast test represent the best criterion for the diagnosis of endogenous hyperinsulinism, reaching 100% diagnostic specificity and sensitivity. Concomitant C-peptide levels above 0.2 nmol/l also make the diagnosis of all our insulinoma patients, not the diagnosis of nesidioblastosis, while insulin levels have much less diagnostic accuracy. Whether proinsulin levels above 22 pmol/l could also make the diagnosis of endogenous hyperinsulinism in part of the patients at the time of fasting blood glucose levels between 2.5 and 3.3 mmol/l or after an overnight fast in non-obese subjects needs further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in one series the plasma insulin criterion was met in 29 of 32 patients with an insulinoma, whereas the C-peptide and proinsulin criteria were met in all 32 patients (61).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [61]
Citations
Cites
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., & Gorden, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6807 · Cited by 256 · cited 10×
“In the past years, ratios calculated with insulin, blood glucose levels, then with proinsulin and insulin levels had been recommended (1, 3, 7 ). New assays leading to sensitive and specific evaluation of insulin, C-peptide and proinsulin are now in use and several thresholds were determined in order to make the diagn…”
BackgroundMethodInfluentialService, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Automated kinetic method for D-3-hydroxybutyrate in plasma or serum
McMurray, C. H., Blanchflower, W. J., & Rice, D. A. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.3.421 · Cited by 188
Noninsulinoma pancreatogenous hypoglycemia syndrome: An update in 10 surgically treated patients
Thompson, G. B., Service, F. J., Andrews, J. C., Lloyd, R. V., Natt, N., van Heerden, J. A., & Grant, C. S. (2000) · Surgery · doi:10.1067/msy.2000.110243 · Cited by 121
Homeostasis During Fasting. II. Hormone Substrate Differences Between Men and Women
MERIMEE, T. J., & FINEBERG, S. E. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-698 · Cited by 82 · cited 1×
“First, we confirm that healthy subjects can have blood glucose levels below 3.3 mmol/l or even below 2.5 mmol/l during the fast test (1, 22 ), the lowest level being above 2 mmol/l (2.3 mmol/l) in our study.”
BackgroundInfluentialProinsulin by immunochemiluminometric assay for the diagnosis of insulinoma
Kao, P. C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1048 · Cited by 65 · cited 2×
“When blood glucose levels are between 2.5 and 3.3 mmol/l during the fast test, insulin and C-peptide levels overlapped between controls and patients ( 9 ).”
BackgroundInfluentialInvestigation of hypoglycaemia
Marks, V., & Teale, J. D. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.659478.x · Cited by 51 · cited 2×
“Then, a 6 mIU/l (43 pmol/l) insulin threshold and a 0.6 ng/ml (0.2 nmol/l) C-peptide threshold concomitant with symptomatic hypoglycaemia below 0.45 g/l (2.5 mmol/l) was established by Service et al. (1), while others recommended cut-off values of 5 mIU/l (36 pmol/l) and 0.9 ng/ml (0.3 nmol/l) at the time of hypoglyca…”
BackgroundMethodInfluentialVezzosi, D., Bennet, A., Fauvel, J., Boulanger, C., Tazi, O., Jp, L., & Caron, P. J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490413 · Cited by 49 · cited 1×
“In the present study, we confirm our previous finding that at the time of hypoglycaemia below 2.5 mmol/l, several patients (11–35%) with endogenous hyperinsulinism have insulin levels below 21 pmol/l ( 4 ).”
ResultInfluentialSelf-citationInsulin surrogates in insulinoma
O'Brien, T. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.448 · Cited by 47 · cited 1×
“Hypoglycaemia related to endogenous hyperinsulinism was excluded if, during the 72-h fast test, blood glucose did not decrease below 3.3 mmol/l or if serum b-hydroxybutyrate concentrations reached 2700 mmol/l with concomitant blood glucose between 2.5 and 3.3 mmol/l (10, 11 ).”
BackgroundInfluentialStarke, A., Saddig, C., Kirch, B., Tschahargane, C., & Goretzki, P. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0543-6 · Cited by 46 · cited 2×
“Moreover, it has been shown that patients with nesidioblastosis and even some rare glucose-sensitive insulinoma patients can undergo a 72-h fast test without hypoglycaemia ( 15 ) ,s uch patients being detected only with an oral glucose tolerance test (OGTT) or a meal test.”
Background
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Diagnosis and Management of Insulinoma
Okabayashi, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.829 · Cited by 482
Öberg, K. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.014 · Cited by 189
Glucose Metabolism After Renal Transplantation
Hecking, M., Kainz, A., Werzowa, J., Haidinger, M., Döller, D., Tura, A., Karaboyas, A., Hörl, W. H., Wolzt, M., Sharif, A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2441 · Cited by 122
“Laboratory measurements At MUV, glucose was assessed by the hexokinase method, glycated hemoglobin A1C (HbA1c) was assessed by highperformance liquid chromatography separation of hemoglobin fractions (18), and insulin was assessed by chemiluminescence immunoassay (19).”
MethodIsmail, A. A. A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1255 · Cited by 100
“(2007; on 33 patients) [63] and Guettier et al.”
BackgroundOccult sporadic insulinoma: Localization and surgical strategy
Abboud, B., & Boujaoude, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.657 · Cited by 103
Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults
Patel, N., Taveira, T. H., Choudhary, G., Whitlatch, H. B., & Wu, W. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003152 · Cited by 89
Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery
Malik, S., Mitchell, J. E., Steffen, K., Engel, S., Wiisanen, R., Garcia, L., & Malik, S. A. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.07.003 · Cited by 86
Banerjee, I., Skae, M. S., Flanagan, S. E., Rigby, L., Patel, L., Didi, M., Blair, J., Ehtisham, S., Ellard, S., Cosgrove, K. E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1136 · Cited by 86
Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors
Anderson, C. W., & Bennett, J. (2016) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.12.003 · Cited by 92
Diagnosis of Pancreatic Neuroendocrine Tumors
Lee, D. W., Kim, M. K., & Kim, H. G. (2017) · Clinical Endoscopy · doi:10.5946/ce.2017.131 · Cited by 92
“Proinsulin levels are also elevated in insulinoma (Table 4).(10,11) When gastrinoma is suspected, fasting serum gastrin levels should be evaluated.”
BackgroundMyint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1065 · Cited by 77
Druce, M. R., Muthuppalaniappan, V. M., O’Leary, B., Chew, S. L., Drake, W. M., Monson, J. P., Akker, S. A., Besser, M., Sahdev, A., Rockall, A., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0056 · Cited by 79
Honma, K., Hikosaka, M., Mochizuki, K., & Goda, T. (2015) · Metabolism · doi:10.1016/j.metabol.2015.12.003 · Cited by 78
“In general, many animals and humans with insulin resistance had higher blood insulin concentrationsduring fasting [17,20,21].”
BackgroundGrowth factor control of pancreatic islet regeneration and function
Assmann, A., Hinault, C., & Kulkarni, R. N. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00468.x · Cited by 68
Disorders of glucose metabolism: post mortem analyses in forensic cases–part II
Mußhoff, F., Heß, C., & Madea, B. (2010) · International Journal of Legal Medicine · doi:10.1007/s00414-010-0510-0 · Cited by 71
“evidence that any insulin that is present is of endogenous origin, too [47].”
BackgroundMurder by insulin: suspected, purported and proven—a review
Marks, V. (2009) · Drug Testing and Analysis · doi:10.1002/dta.38 · Cited by 70
Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia
De León, D. D., & Stanley, C. A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.06.005 · Cited by 63
“Very different results were reported in another study using different cut-offs (25) and including a smaller sample size.”
BackgroundResultCeppa, E. P., Ceppa, D. P., Omotosho, P. A., Dickerson, J. A., Park, C. W., & Portenier, D. D. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.08.008 · Cited by 59
Fottner, C., Ferrata, M., & Weber, M. M. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9438-8 · Cited by 64
“3 mmol/l) show is a considerable overlap of insulin and C-peptide levels between patients and controls [30].”
BackgroundMethodInfluentialPancreatic neuroendocrine tumors: contemporary diagnosis and management
Parbhu, S. K., & Adler, D. G. (2016) · Hospital Practice · doi:10.1080/21548331.2016.1210474 · Cited by 57
Church, D., Cardoso, L., Kay, R. G., Williams, C. L., Freudenthal, B., Clarke, C., Harris, J. R., Moorthy, M., Karra, E., Gribble, F. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00972 · Cited by 46
Thies, J.-W., Kuhn, P., Thürmann, B., Dübel, S., & Dietzel, A. H. (2017) · Microelectronic Engineering · doi:10.1016/j.mee.2017.04.023 · Cited by 43
Nauck, M. A., & Meier, J. J. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00004 · Cited by 44
Khoury, T., Sbeit, W., & Napoléon, B. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.157 · Cited by 44
Spontaneous hypoglycemia: diagnostic evaluation and management
Kandaswamy, L., Raghavan, R., & Pappachan, J. M. (2016) · Endocrine · doi:10.1007/s12020-016-0902-0 · Cited by 42
“5 mmol/L) during a prolonged fast [24].”
Clinical features of pancreatic neuroendocrine tumors
Grozinsky‐Glasberg, S., Mazeh, H., & Gross, D. J. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.226 · Cited by 38
“The age of the patient at the time of diagnosis is 47 ±16years (mean±SD), with a female predominance (66%) [19].”
BackgroundPancreatic insulinomas: Laparoscopic management
Antonakis, P. T., Ashrafian, H., & Martínez-Isla, A. (2015) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v7.i16.1197 · Cited by 34
Type 2 Diabetes Mellitus and Glucagon Like Peptide-1 Receptor Signalling
Aiysha Thompson, K. (2013) · Clinical & Experimental Pharmacology · doi:10.4172/2161-1459.1000138 · Cited by 33
“5 times longer than insulin and therefore higher concentrations exist in the peripheral circulation and levels fluctuate less [41].”
BackgroundA Clinicopathological Study of Malignant Insulinoma in a Contemporary Series
Yu, R., Nissen, N. N., Hendifar, A., Tang, L. A., Song, Y., Chen, Y., & Fan, X. (2016) · Pancreas · doi:10.1097/mpa.0000000000000718 · Cited by 29
Peptide Antibodies in Clinical Laboratory Diagnostics
Trier, N. H., & Houen, G. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.01.002 · Cited by 27
Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia
Coelho, C., Druce, M. R., & Grossman, A. B. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.198 · Cited by 26
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas.
Toaiari, M., Davì, M. V., Carbonare, L. D., Boninsegna, L., Castellani, C., Falconi, M., & Francia, G. (2013) · PubMed · doi:10.3275/8942 · Cited by 29
Endocrine Tumors of the Pancreas and Gastrointestinal Tract
Jensen, R. T., & Norton, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00032-9 · Cited by 28
Liu, T., Chen, M., Ren, Z., Hou, J., Lin, G., & Wu, Y. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.016 · Cited by 22
Zhao, K., Patel, N., Kulkarni, K., Gross, J., & Taslakian, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103091 · Cited by 26
“Additionally, elevated C-Peptide and pro-insulin levels have been shown to have greater diagnostic accuracy for the diagnosis of endogenous hyperinsulinism than insulin levels [10].”
BackgroundStratakis, N., Siskos, A., Papadopoulou, E., Nguyen, A. N., Zhao, Y., Margetaki, K., Lau, C. E., Coen, M., Maître, L., Fernández‐Barrés, S., et al. (2022) · eLife · doi:10.7554/elife.71332 · Cited by 28
“C-peptide has a longer half ‐ life than insulin and is recognized as a stable and accurate marker of endogenous insulin secretion, even in nonfasting conditions ( Hope et al., 2016 ; Vezzosi et al., 2007 ; Polonsky et al., 1986 ).”
BackgroundFast test: Clinical practice and interpretation
Agin, A., Charrié, A., Chikh, K., Tabarin, A., & Vezzosi, D. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.05.003 · Cited by 21
Self-citationDieterle, M. P., Husari, A., Prozmann, S. N., Wiethoff, H., Stenzinger, A., Röhrich, M., Pfeiffer, U., Kießling, W. R., Engel, H., Sourij, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061732 · Cited by 19
Gomez-Perez, F. J., Ramos, D. C., Valdés, P. A., Aguilar-Salinas, C. A., Mehta, R., & Rull, J. A. (2010) · Endocrine Practice · doi:10.4158/ep10016.cr · Cited by 18
Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma
Dauben, L., Simon, M., Straßburger, K., Burkart, V., Weber, K. S., Schinner, S., Roden, M., & Müssig, K. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0879 · Cited by 19
Engel, Helfrich, Manderscheid, Musholt, Forst, Pfützner, & Dahmen (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s18455 · Cited by 16
Diagnostics and treatment of insulinoma
KOREN, S. K. M. (2015) · Neoplasma · doi:10.4149/neo_2015_083 · Cited by 20
“In addition, generally high level of proinsulin secreted by insulinoma cells is more suitable diagnostic marker [36].”
BackgroundBuffet, A., Vezzosi, D., Maiza, J. C., Grunenwald, S., Bennet, A., & Caron, P. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0020 · Cited by 15
Self-citationThies, J.-W., Thürmann, B., Vierheller, A., & Dietzel, A. H. (2018) · Micromachines · doi:10.3390/mi9040194 · Cited by 15
“45 μg/L) and inhibits a key function in the regulation of the glucose level within blood [7]—the limit of detection is not sufficient without signal enhancement techniques.”
BackgroundClinical Implications of Various Criteria for the Biochemical Diagnosis of Insulinoma
Ahn, C. H., Kim, L.-K., Lee, J. E., Jung, C.-H., Min, S.-H., Park, K. S., Kim, S. Y., & Cho, Y. M. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.498 · Cited by 14
Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia
Sakakibara, A., Hashimoto, Y., Kawakita, R., Hosokawa, Y., Nagahara, K., Hasegawa, Y., Hoshino, S.-I., Nagasaka, H., & Yorifuji, T. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12548 · Cited by 15
“Others have proposed the use of C-peptide, instead of insulin, because insulin is relatively unstable in the blood, and the secretion could be episodic.(11,12) In addition, robust glycemic response to glucagon at the time of hypoglycemia, are also useful.”
BackgroundChristesen, H. T., Christensen, L. G., Löfgren, Å. M., Brøndum‐Nielsen, K., Svensson, J., Brusgaard, K., Samuelsson, S., Elfving, M., Jonson, T., Grønskov, K., et al. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.02.004 · Cited by 14
Hypoglycemia in the toddler and child
Langdon, D. R., Stanley, C. A., & Sperling, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00030-5 · Cited by 15
Liao, J., Ding, F., Luo, W., Nie, X., He, Y., & Li, G. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06379-z · Cited by 13
Diagnostic performance of the ARCHITECT C-Peptide immunoassay
Schultess, J., van Duren, C., Martens, M. F. W. C., Costa, M., Llop, T., Martí, T., Eppinger, M., Hausmann, M., Krack, W., & Dhein, J. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.185 · Cited by 12
Ueda, K., Kawabe, K., Lee, L., Tachibana, Y., Fujimori, N., Igarashi, H., Oda, Y., Jensen, R. T., Takayanagi, R., & Ito, T. (2017) · Pancreas · doi:10.1097/mpa.0000000000000772 · Cited by 12
Gjelberg, H. K., Hoem, D., Verbeke, C. S., Eide, J., Cooper, J. G., & Molven, A. (2017) · Clinical Case Reports · doi:10.1002/ccr3.927 · Cited by 12
“2 nmol/L in a patient with hypoglycemia is suggestive of insulinoma [5, 14].”
BackgroundCazabat, L., & Chanson, P. (2009) · Annales d Endocrinologie · doi:10.1016/s0003-4266(09)72470-9 · Cited by 10
Hyperinsulinemic Hypoglycemia after Bariatric Surgery
Hu, S., Tang, H., Wang, H., Dong, Z., Jiang, S., Wang, C., Chen, X., & Yang, W. (2020) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2020.9.1.1 · Cited by 8
“insulinomas compared to nesidioblastosis [12,13].”
Asymptomatic insulinoma: A case report and autopsy series
Kishi, S., Sakamoto, K., Mori, M., Isogawa, A., & Shiba, T. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.007 · Cited by 8
“The most recommended method for the evaluation of endogenous insulin hypersecretion is a supervised 72-h fasting test, a study with excellent sensitivity and specificity [4].”
BackgroundMethodBonnet-Serrano, F., Genteuil, C. D., Thomeret, L., Laguillier, C., Leguy, M.-C., Vaczlavik, A., Bouys, L., Zientek, C., Bricaire, L., Bessiène, L., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad012 · Cited by 7
Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma
Bódis, K. B., Schön, M., Dauben, L., Wilker, M., Straßburger, K., Burkart, V., Roden, M., & Müssig, K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad618 · Cited by 9
Tartaglia, A., Busonero, G., Gagliardi, L., Boddi, V., Pieri, F., & Nizzoli, M. (2022) · Discover Oncology · doi:10.1007/s12672-022-00531-z · Cited by 7
“Hypoglycemic episodes occur mostly during fasting periods and sometimes during the post-prandial phase [7, 8].”
BackgroundTavčar, I., Kikovic, S., Bezmarević, M., Rusovic, S., Perisic, N., Mirković, D., Kuzmic-Jankovic, S., Dragovic, T., Karajovic, J., & Hajdukovic, Z. (2013) · Vojnosanitetski pregled · doi:10.2298/vsp130415048t · Cited by 9
Medical therapy in patients with endogenous hypoglycaemia: Is euglycaemia achievable?
Vezzosi, D., Guillaume, E., Bennet, A., Mouly, C., Hanaire, H. P., & Caron, P. J. (2019) · Clinical Endocrinology · doi:10.1111/cen.13961 · Cited by 7
Self-citationDiagnosis and Treatment of Insulinomas in the Adults
Vezzosi, D., Bennet, A., Maïza, J.-C., Buffet, A., Grunenwald, S., Fauvel, J., Courbon, F., Otal, P., Carrère, N., & Caro, P. (2011) · InTech eBooks · doi:10.5772/17452 · Cited by 8
Self-citationYu, J., Liu, Y., Lyu, L., Zhao, Y. Z., Qi, M., Ping, F., Xu, L., Li, W., Xu, Q., Zhang, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.994707 · Cited by 6
“Because b-cell polypeptide secretion is associated with blood glucose, especially in healthy individuals, the diagnostic performance of insulin, C-peptide, and proinsulin can be different with different concomitant glucose levels (11, 12).”
BackgroundResultInfluentialUn insulinome géant : à propos d’un cas
Ketari-Jamoussi, S., Debbiche-Chedly, A., Dhaou, B. B., BOUSSEMA, F., Cherif, O., Cherif, A. R., Ayed, M. B., Bouzaine, A., & ROKBANI, L. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.005 · Cited by 6
“[4] Vezzosi D, Bennet A, Fauvel J, Caron P.”
Background[Hyperinsulinemic hypoglycemia in adults. Case reports and a short review].
Kovács, E., Nemeth, H., Pásztor, É., & Pfliegler, G. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28399 · Cited by 8
Short fasting test as a reliable and effective tool to diagnose insulinoma
Mikovic, N., Mazzilli, R., Zamponi, V., Russo, F., Mancini, C., Mori, F., Bollanti, L., Conti, F., Motta, C., Monti, S., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03759-7 · Cited by 7
“…following a 12-h overnight fast in several different days, 76% patients showed glycaemia ≤ 50 mg/dL and in 86% ≤ 60 mg/dl. Vezzosi and colleagues [18] applied the same protocol: in their study, 88% of the subjects showed glycaemia 60 mg/dL, concluding that it could be used as triage do exclude…”
MethodDiagnosis and Management of Benign Secreting Pancreatic Insulinoma: What’s New? 4 Case Report
Bahou, K., Achour, Y., Ilahiane, M., Sekkat, H., Bakali, Y., Mhamdi Alaoui, M., Raiss, M., Sabbah, F., & Hrora, A. (2025) · Rare Tumors · doi:10.1177/20363613241313409 · Cited by 5
Hiperinsulinismo endógeno: revisão e seguimento de 24 casos
Felício, J. S., Martins, C. L. E. L. P., Semer, M., Kalinin, L. B., Nery, M., Machado, M. C. C., & Liberman, B. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000200001 · Cited by 7
[Nesidioblastosis as a cause of hyperinsulinism in the adult].
Ballester, M., Flores-Pastor, B., Pascual, H., Pallares, J. T., & Aguayo-Albasini, J. L. (2010) · Cirugia Española · doi:10.1016/j.ciresp.2010.02.007 · Cited by 6
Anthropometric Features are not Predictive of 72-Hour Fast Duration in Insulinomas
Donegan, D. M., Jakubíková, I., & Vella, A. V. (2017) · Endocrine Practice · doi:10.4158/ep171872.or · Cited by 5
“hydroxybutyrate at fast termination (mmol/L) Median tumor diameter, mm (range) 14 (1- 97) 14 (6-97) 15 (1-90)”
BackgroundSampaio-Neto, J., Branco-Filho, A. J., Nassif, L., Nassif, A. T., Masi, F. D. J. D., & Ximenez, D. (2015) · Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · doi:10.1590/s0102-6720201500040015 · Cited by 4
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Seaquist, E. R., Service, F. J., & on behalf of the Endocrine Society Task Force on the Evaluation and Management of Adult Hypoglycemic Disorders (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-6-201303190-00020 · Cited by 6
Association of Insulinoma and Type 2 Diabetes Mellitus
Ouleghzal, H., Ziadi, T., Menfaa, M., & Safi, S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.39439 · Cited by 4
“Biologically, the presence of hypoglycemia with inadequately high C-peptide and insulin levels evokes the diagnosis (4) such as the case of our patient.”
BackgroundA 14-Year Old Girl with Reversible Hypoglycemic Episodes: The Role of ASVS
Smith, A., THORNTON, P. S., GALLIANI, C. A., Miller, J., Dykes, J., & Leung‐Pineda, V. (2014) · Pediatric and Developmental Pathology · doi:10.2350/14-08-1537-cr.1 · Cited by 4
“Normal pancreatic b-cells suppress insulin secretion in response to a decrease in glucose concentration [5].”
BackgroundCryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 7
Stratakis, N., Siskos, A., Papadopoulou, E., Nguyen, A. N., Zhao, Y., Margetaki, K., Lau, C. E., Coen, M., Maître, L., Fernández‐Barrés, S., et al. (2021) · medRxiv · doi:10.1101/2021.09.09.21263335 · Cited by 4
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Kızılgül, M., & Delibaşı, T. (2014) · Translational gastrointestinal cancer · Cited by 4
Soyoye, D. O., Atolani, S. A., Adetunji, T. A., & Alatise, O. I. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad162 · Cited by 4
Silva, J. F., Meireles, S., Falconi, M., Fernandes, A., Boas, F. V., Bispo, M., Rio‐Tinto, R., Rodrigues‐Pinto, E., & the Portuguese Pancreatic Club, S. S. O. T. P. S. O. G. (2023) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000534641 · Cited by 4
“If insulinoma is suspected, serum level of insulin and C-peptide along with glucose during prolonged fasting (72 h) is useful for the diagnosis [7].”
MethodGenotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia.
Larsen, A. R., Brusgaard, K., Christesen, H. T., & Detlefsen, S. (2024) · PubMed · doi:10.14670/hh-18-709 · Cited by 7
Bowsher, R. R., & Santa, P. F. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.035 · Cited by 3
Takahashi, N., Nagamine, M., Fukuda, M., Motomura, W., Abiko, A., Haneda, M., Fujiya, M., Ieko, M., & Kohgo, Y. (2011) · Case Reports in Medicine · doi:10.1155/2011/381203 · Cited by 3
Nesidioblastosis following laparoscopic sleeve gastrectomy
Kim, A. S., Snaith, J., Mahajan, H., & Holmes-Walker, D. J. (2019) · Clinical Endocrinology · doi:10.1111/cen.14083 · Cited by 3
Schäffler, A., & Karrasch, T. (2024) · Springer eBooks · doi:10.1007/978-3-662-70260-4_2 · Cited by 3
Glucagon test in insulinoma: Is it useful?
Felício, J. S., Martins, C. L. L. P., Miléo, K. B., Semer, M., Kalinin, L., Nery, M., Machado, M. C. C., & Liberman, B. (2012) · PubMed · doi:10.3275/7879 · Cited by 3
Winter, W. E., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00007-8 · Cited by 2
How should we differentiate hypoglycaemia in non-diabetic patients?
Modestino, M. R., Iacono, O., Ferrentino, L., Lombardi, A., Fortuna, U. D., Verdoliva, R., Luca, M. D., & Guardasole, V. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2024-0030 · Cited by 5
Loo, F. J. J., Lee, M. K. S., Huang, H. L., Vu, C. K. F., & Kon, Y. C. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae232 · Cited by 2
Study of conformational mobility of insulin, proinsulin, and insulin-like growth factors
Ksenofontova, O., Romanovskaya, E. V., & Стефанов, В. Е. (2014) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209301401006x · Cited by 2
“Besides, this ratio is used for diagnostics of the pancreas tumors (by insulin) [11].”
MethodSpontanhypoglykämien: Insulinome und Differenzialdiagnosen
Nauck, M. A., & Meier, J. J. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0914-1 · Cited by 2
Insulinoma and Chronic Kidney Disease: An Uncommon Conundrum Not to Be Overlooked
Foppiani, L., Panarello, S., Filauro, M., Scirocco, M. C., Cappato, S., Parodi, A. F., Sola, S., & Antonucci, G. (2017) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551417742620 · Cited by 2
Diaz-Puentes, M., Colon, C. A., & Rosselli, D. (2019) · IATREIA · doi:10.17533/udea.iatreia.14 · Cited by 3
“The correlation is made with insulin, C-peptide and proinsulin (4).”
BackgroundAlhammer, A. H. (2015) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2015.9.1.391 · Cited by 3
Alternative cause for hypoglycaemia in insulin-treated diabetes mellitus
Parmar, V., Sritharan, V., Lawrence, C., & Dhere, A. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-241439 · Cited by 2
Case 33-2012: A Woman with Altered Mental Status after Childbirth
Mukaddam, M. A., Baloch, Z. W., & Rickels, M. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1214187 · Cited by 2
Metadata
- Authors
- Vezzosi, D., Bennet, A., Fauvel, J., & Caron, P.
- Affiliations
- Hôpital Rangueil (FR)
- Corresponding author
- Caron, P
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07
- Volume
- 157
- Issue
- 1
- Pages
- 75-83
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2110510376
- Cited by
- 152
- References
- 19
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 10 · 2015: 13 · 2014: 10 · 2013: 16 · 2012: 10
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- endogenous hyperinsulinism, hypoglycemia, insulinoma, proinsulin, C-peptide, insulin, biochemical diagnosis, nesidioblastosis, fasting blood glucose, diagnostic thresholds
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, C-Peptide, Circadian Rhythm, Diagnostic Techniques, Endocrine, Fasting, Female, Humans, Hyperinsulinism, Hypoglycemia, Insulin, Male, Middle Aged, Proinsulin, Sensitivity and Specificity, Time Factors, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.